Account
Inquiry
Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic research applications. Our pharmaceutical grade tirzepatide offers researchers high purity material at competitive tirzepatide prices.
This innovative peptide demonstrates superior efficacy in glucose control and weight management compared to single receptor agonists. The dual mechanism of action makes tirzepatide particularly valuable for metabolic disorder research.
Our tirzepatide peptide powder features:
- 99.9% purity by HPLC analysis
- White powder appearance
- Standard packaging of 10mg/vial, 10 vials/box
- Minimum order quantity of 10 vials
Tirzepatide's molecular structure includes a PEG-modified lysine side chain that enhances water solubility while maintaining biological activity. The peptide shares sequence similarity with semaglutide but offers enhanced receptor binding characteristics.
For research purposes, tirzepatide has shown promising results in weight management studies, with clinical data indicating significant reductions in body weight at various dosage levels. These properties make it valuable for metabolic research applications.
As a manufacturer, we offer flexible ordering options including bulk quantities and custom formulations. Our competitive tirzepatide prices make this innovative peptide accessible for research institutions and pharmaceutical developers.
Proper storage is essential for maintaining peptide integrity. We recommend storing tirzepatide in a cool, dry environment protected from light and moisture. Avoid repeated freeze-thaw cycles and prolonged exposure to air.
Note: This product is intended for research use only. Not for human consumption or diagnostic use.
